Social Media Influencers Driving Parallel Trade for Unlicensed Slimming Drug
A shadow market for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on communication apps, based on new investigations.
Experimental Treatment Gaining Popularity Via Social Media
The experimental drug, which is still in research studies, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are urged to message these profiles directly for supplier links, while also receiving discount codes.
Thriving Trade on Social Networks
Separately, a flourishing trade exists on Telegram, where communities with thousands of members share comparison images, administration instructions and claims of rapid British shipping. Vendors market the drug there before directing buyers to other platforms for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Medical Experts Voice Worries
However, doctors and pharmacists have cautions that the distribution of what is still an unapproved medication in the United Kingdom is worrisome and could result in individuals injecting products of uncertain source.
Several professionals stated the popularity for retatrutide could be connected to the rising cost of approved weight loss treatments such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for human use under the British medical regulations.
Some content creators attempt to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still breach pharmaceutical, marketing, and customer regulations, risking fines, legal action or imprisonment.
Service Reaction and Material Removal
According to TikTok, the platform has removed violative content and banned associated hashtags and search suggestions. The company stated it was dedicated to maintaining the service secure and allocating resources in strengthening enforcement strategies.
Online Marketplace Operations
Investigations also found groups with up to nine thousand members selling the experimental drug using Telegram's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of members, filled with images of slimming results, positive reviews and detailed guides for mixing or injecting at residence.
Within moments of joining one group, a vendor shared contact information, where most purchases take place. The seller provided an guidebook and guaranteed shipping within two days. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about weight, health issues or past usage.
Product Details and Pricing
Within these communities, messages display black plastic packages with Royal Mail stickers, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with purified liquid, or pre-filled pens usually sold at £160 for 20 milligrams. When asked how long a injector should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.
Platform Moderation and Security Measures
A spokesperson for Telegram stated it regularly monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are administering substances they can’t verify. Even if the research behind retatrutide is sound, these online products may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the surge in demand to current cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.
Her staff has previously seen patients injured by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” said the doctor. “These materials could be contaminated or improperly measured.”
Manufacturer Position
A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company experimental product not yet approved … may subject patients to potentially serious health risks”.